This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Mahender Gurram, Ph.D.
Senior Director, DS Development, Mfg, & CMC at Entrada Therapeutics
Speaker

Profile

Trained synthetic organic chemist with >15 years of experience in synthesis of drug substances, intermediates in CROs and in innovative Biotechs. Significant experience in clinical and late phase product development and CMC. Currently overseeing development and manufacturing of PMOs and related drug substances at Entrada therapeutics.

Agenda Sessions

  • Strategies for Oligonucleotides Purification Applicable for Clinical Products Manufacture

    11:45am